XXXX in @entity6 .

@entity1 @entity455 @entity6 @entity2054 @entity613 @entity164 @entity158
AIMS: @entity613 is common in @entity6 and usually (attributed to @entity455 ) . However, a proportion of @entity1 with @entity6 have symptoms of @entity613 without signs of @entity455 and these @entity1 were evaluated for chronic @entity2054 . METHODS: Forty-two @entity1 with @entity6 (10 @entity1 , 32 @entity1 ), earlier investigated at @entity6 clinics because of @entity613 with no explanation for the symptoms, were examined. Their median age was 48 years (18-72 years) and the median duration of @entity6 was 29 years (1-45 years). Thirty-one @entity1 had @entity164 1 @entity6 , 11 had @entity164 2 @entity6 and 29 had @entity6 complications. All were investigated clinically, with radiography, bone scan and intramuscular pressure measurements. RESULTS: Thirty-eight of 42 @entity1 with @entity6 were diagnosed with chronic @entity2054 of the lower leg and 32 were treated surgically. Thirty-one @entity1 were operated with fasciotomy of the anterior compartment and 18 also with fasciotomy of the posterior compartment. Additionally, one @entity1 had only fasciotomy of the posterior compartment. Fourteen of 32 surgically treated @entity1 (27 legs) were followed for more than 2 years and rated the post-operative outcome as excellent or good in 21 of the treated legs. The walking distance before lower @entity158 increased in all but one @entity1 and seven @entity1 reported unrestricted walking ability. CONCLUSIONS: @entity2054 should be considered as a differential diagnoses in @entity1 with @entity6 and exercise-related lower @entity158 . The results after surgery are encouraging and the increased walking ability is beneficial in the treatment of @entity6 .
